Matches in SemOpenAlex for { <https://semopenalex.org/work/W2551009765> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2551009765 endingPage "5488" @default.
- W2551009765 startingPage "5488" @default.
- W2551009765 abstract "Abstract To develop a new therapeutic monoclonal Antibody (mAb) for Hodgkin lymphoma (HL), we immunized a BALB/c mouse with live HL cell lines, alternating between two HL cell lines. After hybridization, we screened the hybridoma clones by assessing direct cytotoxicity against a HL cell line not used for immunization. We developed this strategy for establishing mAb to reduce the risk of obtaining clonotypic mAb specific for single HL cell line. A newly established mouse anti-human mAb (4713) triggered cytoskeleton-dependent, but complement- and caspase-independent, cell death in HL cell lines, Burkitt lymphoma cell lines, and advanced adult T-cell leukemia cell lines. Intravenous injection of mAb 4713 in tumor-bearing SCID mice improved survival significantly. mAb 4713 was revealed to be a mouse anti-human pan-HLA class II mAb. Treatment with this mAb induced the formation of large pores on the surface of target lymphoma cells within 30 min. This finding suggests that the cell death process induced by this anti-pan HLA-class II mAb may involve the same death signals stimulated by a cytolytic anti-pan MHC class I mAb that also induces large pores formation. This multifaceted study supports the therapeutic potential of mAb 4713 for various forms of lymphoma. Disclosures No relevant conflicts of interest to declare." @default.
- W2551009765 created "2016-11-30" @default.
- W2551009765 creator A5017240065 @default.
- W2551009765 creator A5030054980 @default.
- W2551009765 creator A5046924425 @default.
- W2551009765 creator A5049797235 @default.
- W2551009765 creator A5059219602 @default.
- W2551009765 creator A5066609674 @default.
- W2551009765 creator A5090254870 @default.
- W2551009765 date "2014-12-06" @default.
- W2551009765 modified "2023-10-16" @default.
- W2551009765 title "Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death Via Large Pore Formation" @default.
- W2551009765 doi "https://doi.org/10.1182/blood.v124.21.5488.5488" @default.
- W2551009765 hasPublicationYear "2014" @default.
- W2551009765 type Work @default.
- W2551009765 sameAs 2551009765 @default.
- W2551009765 citedByCount "0" @default.
- W2551009765 crossrefType "journal-article" @default.
- W2551009765 hasAuthorship W2551009765A5017240065 @default.
- W2551009765 hasAuthorship W2551009765A5030054980 @default.
- W2551009765 hasAuthorship W2551009765A5046924425 @default.
- W2551009765 hasAuthorship W2551009765A5049797235 @default.
- W2551009765 hasAuthorship W2551009765A5059219602 @default.
- W2551009765 hasAuthorship W2551009765A5066609674 @default.
- W2551009765 hasAuthorship W2551009765A5090254870 @default.
- W2551009765 hasBestOaLocation W25510097652 @default.
- W2551009765 hasConcept C109316439 @default.
- W2551009765 hasConcept C147483822 @default.
- W2551009765 hasConcept C153911025 @default.
- W2551009765 hasConcept C159654299 @default.
- W2551009765 hasConcept C170627219 @default.
- W2551009765 hasConcept C190283241 @default.
- W2551009765 hasConcept C202751555 @default.
- W2551009765 hasConcept C203014093 @default.
- W2551009765 hasConcept C207936829 @default.
- W2551009765 hasConcept C2779338263 @default.
- W2551009765 hasConcept C31573885 @default.
- W2551009765 hasConcept C502942594 @default.
- W2551009765 hasConcept C542903549 @default.
- W2551009765 hasConcept C54355233 @default.
- W2551009765 hasConcept C55493867 @default.
- W2551009765 hasConcept C73588182 @default.
- W2551009765 hasConcept C81885089 @default.
- W2551009765 hasConcept C86803240 @default.
- W2551009765 hasConceptScore W2551009765C109316439 @default.
- W2551009765 hasConceptScore W2551009765C147483822 @default.
- W2551009765 hasConceptScore W2551009765C153911025 @default.
- W2551009765 hasConceptScore W2551009765C159654299 @default.
- W2551009765 hasConceptScore W2551009765C170627219 @default.
- W2551009765 hasConceptScore W2551009765C190283241 @default.
- W2551009765 hasConceptScore W2551009765C202751555 @default.
- W2551009765 hasConceptScore W2551009765C203014093 @default.
- W2551009765 hasConceptScore W2551009765C207936829 @default.
- W2551009765 hasConceptScore W2551009765C2779338263 @default.
- W2551009765 hasConceptScore W2551009765C31573885 @default.
- W2551009765 hasConceptScore W2551009765C502942594 @default.
- W2551009765 hasConceptScore W2551009765C542903549 @default.
- W2551009765 hasConceptScore W2551009765C54355233 @default.
- W2551009765 hasConceptScore W2551009765C55493867 @default.
- W2551009765 hasConceptScore W2551009765C73588182 @default.
- W2551009765 hasConceptScore W2551009765C81885089 @default.
- W2551009765 hasConceptScore W2551009765C86803240 @default.
- W2551009765 hasIssue "21" @default.
- W2551009765 hasLocation W25510097651 @default.
- W2551009765 hasLocation W25510097652 @default.
- W2551009765 hasOpenAccess W2551009765 @default.
- W2551009765 hasPrimaryLocation W25510097651 @default.
- W2551009765 hasRelatedWork W1973692620 @default.
- W2551009765 hasRelatedWork W1992169430 @default.
- W2551009765 hasRelatedWork W2009889818 @default.
- W2551009765 hasRelatedWork W2024715901 @default.
- W2551009765 hasRelatedWork W2063428357 @default.
- W2551009765 hasRelatedWork W2067077431 @default.
- W2551009765 hasRelatedWork W2122854061 @default.
- W2551009765 hasRelatedWork W2368460920 @default.
- W2551009765 hasRelatedWork W2380360044 @default.
- W2551009765 hasRelatedWork W2443772760 @default.
- W2551009765 hasVolume "124" @default.
- W2551009765 isParatext "false" @default.
- W2551009765 isRetracted "false" @default.
- W2551009765 magId "2551009765" @default.
- W2551009765 workType "article" @default.